Skip to main content
Erschienen in: Strahlentherapie und Onkologie 6/2014

01.06.2014 | Original article

Stereotactic radiosurgery for treatment of brain metastases

A report of the DEGRO Working Group on Stereotactic Radiotherapy

verfasst von: Prof. Dr. Martin Kocher, M.D., Andrea Wittig, M.D., Marc Dieter Piroth, M.D., Harald Treuer, Ph.D., Heinrich Seegenschmiedt, M.D., Maximilian Ruge, M.D., Anca-Ligia Grosu, M.D., Matthias Guckenberger, M.D.

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

This report from the Working Group on Stereotaktische Radiotherapie of the German Society of Radiation Oncology (Deutsche Gesellschaft für Radioonkologie, DEGRO) provides recommendations for the use of stereotactic radiosurgery (SRS) on patients with brain metastases. It considers existing international guidelines and details them where appropriate.

Results and discussion

The main recommendations are: Patients with solid tumors except germ cell tumors and small-cell lung cancer with a life expectancy of more than 3 months suffering from a single brain metastasis of less than 3 cm in diameter should be considered for SRS. Especially when metastases are not amenable to surgery, are located in the brain stem, and have no mass effect, SRS should be offered to the patient. For multiple (two to four) metastases—all less than 2.5 cm in diameter—in patients with a life expectancy of more than 3 months, SRS should be used rather than whole-brain radiotherapy (WBRT). Adjuvant WBRT after SRS for both single and multiple (two to four) metastases increases local control and reduces the frequency of distant brain metastases, but does not prolong survival when compared with SRS and salvage treatment. As WBRT carries the risk of inducing neurocognitive damage, it seems reasonable to withhold WBRT for as long as possible.

Conclusion

A single (marginal) dose of 20 Gy is a reasonable choice that balances the effect on the treated lesion (local control, partial remission) against the risk of late side effects (radionecrosis). Higher doses (22–25 Gy) may be used for smaller (< 1 cm) lesions, while a dose reduction to 18 Gy may be necessary for lesions greater than 2.5–3 cm. As the infiltration zone of the brain metastases is usually small, the GTV–CTV (gross tumor volume–clinical target volume) margin should be in the range of 0–1 mm. The CTV–PTV (planning target volume) margin depends on the treatment technique and should lie in the range of 0–2 mm. Distant brain recurrences fulfilling the aforementioned criteria can be treated with SRS irrespective of previous WBRT.
Literatur
1.
Zurück zum Zitat Sturm V, Kober B, Höver KH et al (1987) Stereotactic percutaneous single dose irradiation of brain metastases with a linear accelerator. Int J Radiat Oncol Biol Phys 13:279–282 Sturm V, Kober B, Höver KH et al (1987) Stereotactic percutaneous single dose irradiation of brain metastases with a linear accelerator. Int J Radiat Oncol Biol Phys 13:279–282
2.
Zurück zum Zitat Linskey ME, Andrews DW, Asher AL et al (2010) The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:45–68PubMedCentralPubMed Linskey ME, Andrews DW, Asher AL et al (2010) The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:45–68PubMedCentralPubMed
3.
Zurück zum Zitat Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neurooncol 75:5–14PubMed Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neurooncol 75:5–14PubMed
4.
Zurück zum Zitat Tsao MN, Rades D, Wirth A et al (2012) Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2:210–225PubMedCentralPubMed Tsao MN, Rades D, Wirth A et al (2012) Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2:210–225PubMedCentralPubMed
5.
Zurück zum Zitat McDuff SG, Taich ZJ, Lawson JD et al (2013) Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases. J Neurol Neurosurg Psychiatry 84:1384–1391 McDuff SG, Taich ZJ, Lawson JD et al (2013) Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases. J Neurol Neurosurg Psychiatry 84:1384–1391
6.
Zurück zum Zitat Sperduto PW, Chao ST, Sneed PK et al (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655–661PubMed Sperduto PW, Chao ST, Sneed PK et al (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655–661PubMed
7.
Zurück zum Zitat Zindler JD, Rodrigues G, Haasbeek CJ et al (2013) The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery. Radiother Oncol 106:370–374PubMed Zindler JD, Rodrigues G, Haasbeek CJ et al (2013) The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery. Radiother Oncol 106:370–374PubMed
8.
Zurück zum Zitat Park YH, Kim TH, Jung SY et al (2013) Combined primary tumor and extracranial metastasis status as constituent factor of prognostic indices for predicting the overall survival in patients with brain metastases. J Korean Med Sci 28:205–212PubMedCentralPubMed Park YH, Kim TH, Jung SY et al (2013) Combined primary tumor and extracranial metastasis status as constituent factor of prognostic indices for predicting the overall survival in patients with brain metastases. J Korean Med Sci 28:205–212PubMedCentralPubMed
9.
Zurück zum Zitat Sperduto PW, Kased N, Roberge D et al (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419–425PubMedCentralPubMed Sperduto PW, Kased N, Roberge D et al (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419–425PubMedCentralPubMed
10.
Zurück zum Zitat Halasz LM, Rockhill JK (2013) Stereotactic radiosurgery and Stereotactic Radiotherapy for brain metastases. Surg Neurol Int 4:S185–191 Halasz LM, Rockhill JK (2013) Stereotactic radiosurgery and Stereotactic Radiotherapy for brain metastases. Surg Neurol Int 4:S185–191
11.
Zurück zum Zitat Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672PubMed Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672PubMed
12.
Zurück zum Zitat Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45:427–434PubMed Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45:427–434PubMed
13.
Zurück zum Zitat Chougule P, Burton-Williams M, Saris S, Zheng Z, Ponte B, Noren G (2000) Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both. Int J Radiat Oncol Biol Phys 48:114 Chougule P, Burton-Williams M, Saris S, Zheng Z, Ponte B, Noren G (2000) Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both. Int J Radiat Oncol Biol Phys 48:114
14.
Zurück zum Zitat Patil CG, Pricola K, Sarmiento JM, Garg SK, Bryant A, Black KL (2012) Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst Rev 9:CD006121PubMed Patil CG, Pricola K, Sarmiento JM, Garg SK, Bryant A, Black KL (2012) Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst Rev 9:CD006121PubMed
15.
Zurück zum Zitat Wang LG, Guo Y, Zhang X et al (2002) Brain metastasis: experience of the Xi-Jing hospital. Stereotact Funct Neurosurg 78:70–83PubMed Wang LG, Guo Y, Zhang X et al (2002) Brain metastasis: experience of the Xi-Jing hospital. Stereotact Funct Neurosurg 78:70–83PubMed
16.
Zurück zum Zitat Sanghavi SN, Miranpuri SS, Chappell R et al (2001) Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 51:426–434PubMed Sanghavi SN, Miranpuri SS, Chappell R et al (2001) Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 51:426–434PubMed
17.
Zurück zum Zitat Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491PubMed Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491PubMed
18.
Zurück zum Zitat Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134–141PubMedCentralPubMed Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134–141PubMedCentralPubMed
19.
Zurück zum Zitat Li B, Yu J, Suntharalingam M et al (2000) Comparison of three treatment options for single brain metastasis from lung cancer. Int J Cancer 90:37–45PubMed Li B, Yu J, Suntharalingam M et al (2000) Comparison of three treatment options for single brain metastasis from lung cancer. Int J Cancer 90:37–45PubMed
20.
Zurück zum Zitat Fokas E, Henzel M, Hamm K, Surber G, Kleinert G, Engenhart-Cabillic R (2010) Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients. Strahlenther Onkol 186:210–217PubMed Fokas E, Henzel M, Hamm K, Surber G, Kleinert G, Engenhart-Cabillic R (2010) Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients. Strahlenther Onkol 186:210–217PubMed
21.
Zurück zum Zitat Sneed PK, Suh JH, Goetsch SJ et al (2002) A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519–526PubMed Sneed PK, Suh JH, Goetsch SJ et al (2002) A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519–526PubMed
22.
Zurück zum Zitat Pirzkall A, Debus J, Lohr F et al (1998) Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 16:3563–3569PubMed Pirzkall A, Debus J, Lohr F et al (1998) Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 16:3563–3569PubMed
23.
Zurück zum Zitat Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford LD (2005) The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 62:1125–1132PubMed Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford LD (2005) The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 62:1125–1132PubMed
24.
Zurück zum Zitat Rades D, Kueter JD, Hornung D et al (2008) Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT + SRS) for one to three brain metastases. Strahlenther Onkol 184:655–662PubMed Rades D, Kueter JD, Hornung D et al (2008) Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT + SRS) for one to three brain metastases. Strahlenther Onkol 184:655–662PubMed
25.
Zurück zum Zitat Noel G, Medioni J, Valery CA et al (2003) Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer 41:333–343PubMed Noel G, Medioni J, Valery CA et al (2003) Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer 41:333–343PubMed
26.
Zurück zum Zitat Park HS, Chiang VL, Knisely JP, Raldow AC, Yu JB (2011) Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update. Expert Rev Anticancer Ther 11:1731–1738PubMed Park HS, Chiang VL, Knisely JP, Raldow AC, Yu JB (2011) Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update. Expert Rev Anticancer Ther 11:1731–1738PubMed
27.
Zurück zum Zitat Combs SE, Schulz-Ertner D, Thilmann C, Edler L, Debus J (2004) Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery. Strahlenther Onkol 180:590–596PubMed Combs SE, Schulz-Ertner D, Thilmann C, Edler L, Debus J (2004) Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery. Strahlenther Onkol 180:590–596PubMed
28.
Zurück zum Zitat Hoffman R, Sneed PK, McDermott MW et al (2001) Radiosurgery for brain metastases from primary lung carcinoma. Cancer J 7:121–131PubMed Hoffman R, Sneed PK, McDermott MW et al (2001) Radiosurgery for brain metastases from primary lung carcinoma. Cancer J 7:121–131PubMed
29.
Zurück zum Zitat Aoyama H, Tago M, Kato N et al (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68:1388–1395PubMed Aoyama H, Tago M, Kato N et al (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68:1388–1395PubMed
30.
Zurück zum Zitat Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044PubMed Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044PubMed
31.
Zurück zum Zitat Meyers CA, Rock EP, Fine HA (2012) Refining endpoints in brain tumor clinical trials. J Neurooncol 108:227–230PubMed Meyers CA, Rock EP, Fine HA (2012) Refining endpoints in brain tumor clinical trials. J Neurooncol 108:227–230PubMed
32.
Zurück zum Zitat Soffietti R, Kocher M, Abacioglu UM et al (2013) A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65–72PubMed Soffietti R, Kocher M, Abacioglu UM et al (2013) A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65–72PubMed
33.
Zurück zum Zitat Suh JH (2010) Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 362:1119–1127PubMed Suh JH (2010) Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 362:1119–1127PubMed
34.
Zurück zum Zitat Soffietti R, Cornu P, Delattre JY et al (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 13:674–681PubMed Soffietti R, Cornu P, Delattre JY et al (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 13:674–681PubMed
35.
Zurück zum Zitat Kalkanis SN, Kondziolka D, Gaspar LE et al (2010) The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:33–43PubMedCentralPubMed Kalkanis SN, Kondziolka D, Gaspar LE et al (2010) The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:33–43PubMedCentralPubMed
36.
Zurück zum Zitat Fuentes R, Bonfill X, Exposito J (2006) Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer. Cochrane Database Syst Rev 25:CD004840 Fuentes R, Bonfill X, Exposito J (2006) Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer. Cochrane Database Syst Rev 25:CD004840
37.
Zurück zum Zitat Minniti G, Esposito V, Clarke E et al (2013) Multidose stereotactic radiosurgery (9 gy × 3) of the postoperative resection cavity for treatment of large brain metastases. Int J Radiat Oncol Biol Phys 86:623–629PubMed Minniti G, Esposito V, Clarke E et al (2013) Multidose stereotactic radiosurgery (9 gy × 3) of the postoperative resection cavity for treatment of large brain metastases. Int J Radiat Oncol Biol Phys 86:623–629PubMed
38.
Zurück zum Zitat Shaw E, Scott C, Souhami L et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys 47:291–298PubMed Shaw E, Scott C, Souhami L et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys 47:291–298PubMed
39.
Zurück zum Zitat Muacevic A, Wowra B, Siefert A, Tonn JC, Steiger HJ, Kreth FW (2008) Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 87:299–307PubMed Muacevic A, Wowra B, Siefert A, Tonn JC, Steiger HJ, Kreth FW (2008) Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 87:299–307PubMed
40.
Zurück zum Zitat Patchell RA, Tibbs PA, Walsh JW et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500PubMed Patchell RA, Tibbs PA, Walsh JW et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500PubMed
41.
Zurück zum Zitat Patchell RA, Tibbs PA, Regine WF et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485–1489PubMed Patchell RA, Tibbs PA, Regine WF et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485–1489PubMed
42.
Zurück zum Zitat Lippitz B, Lindquist C, Paddick I, Peterson D, O’Neill K, Beaney R (2014) Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev 40:48–59 Lippitz B, Lindquist C, Paddick I, Peterson D, O’Neill K, Beaney R (2014) Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev 40:48–59
43.
Zurück zum Zitat Vecht CJ, Haaxma-Reiche H, Noordijk EM et al (1993) Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 33:583–590PubMed Vecht CJ, Haaxma-Reiche H, Noordijk EM et al (1993) Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 33:583–590PubMed
44.
Zurück zum Zitat Adler JR, Cox RS, Kaplan I, Martin DP (1992) Stereotactic radiosurgical treatment of brain metastases. J Neurosurg 76:444–449PubMed Adler JR, Cox RS, Kaplan I, Martin DP (1992) Stereotactic radiosurgical treatment of brain metastases. J Neurosurg 76:444–449PubMed
45.
Zurück zum Zitat Alexander E, 3rd, Moriarty TM, Davis RB et al (1995) Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87:34–40PubMed Alexander E, 3rd, Moriarty TM, Davis RB et al (1995) Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87:34–40PubMed
46.
Zurück zum Zitat Flickinger JC, Kondziolka D, Lunsford LD et al (1994) A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28:797–802PubMed Flickinger JC, Kondziolka D, Lunsford LD et al (1994) A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28:797–802PubMed
47.
Zurück zum Zitat Levitt MR, Levitt R, Silbergeld DL (2013) Controversies in the management of brain metastases. Surg Neurol Int 4:S231–S235 Levitt MR, Levitt R, Silbergeld DL (2013) Controversies in the management of brain metastases. Surg Neurol Int 4:S231–S235
48.
Zurück zum Zitat Rades D, Kieckebusch S, Haatanen T, Lohynska R, Dunst J, Schild SE (2008) Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis. Int J Radiat Oncol Biol Phys 70:1319–1324PubMed Rades D, Kieckebusch S, Haatanen T, Lohynska R, Dunst J, Schild SE (2008) Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis. Int J Radiat Oncol Biol Phys 70:1319–1324PubMed
49.
Zurück zum Zitat Gans JH, Raper DM, Shah AH et al (2013) The role of radiosurgery to the tumor bed after resection of brain metastases. Neurosurgery 72:317–326PubMed Gans JH, Raper DM, Shah AH et al (2013) The role of radiosurgery to the tumor bed after resection of brain metastases. Neurosurgery 72:317–326PubMed
50.
Zurück zum Zitat Connolly EP, Mathew M, Tam M et al (2013) Involved field radiation therapy after surgical resection of solitary brain metastases–mature results. Neuro Oncol 15:589–594PubMedCentralPubMed Connolly EP, Mathew M, Tam M et al (2013) Involved field radiation therapy after surgical resection of solitary brain metastases–mature results. Neuro Oncol 15:589–594PubMedCentralPubMed
51.
Zurück zum Zitat Wang CC, Floyd SR, Chang CH et al (2012) Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen. J Neurooncol 106:601–610PubMed Wang CC, Floyd SR, Chang CH et al (2012) Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen. J Neurooncol 106:601–610PubMed
52.
Zurück zum Zitat Prabhu R, Shu HK, Hadjipanayis C et al (2012) Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control. Int J Radiat Oncol Biol Phys 83:e61–e66 Prabhu R, Shu HK, Hadjipanayis C et al (2012) Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control. Int J Radiat Oncol Biol Phys 83:e61–e66
53.
Zurück zum Zitat Kelly PJ, Lin YB, Yu AY et al (2012) Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique. Int J Radiat Oncol Biol Phys 82:95–101PubMed Kelly PJ, Lin YB, Yu AY et al (2012) Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique. Int J Radiat Oncol Biol Phys 82:95–101PubMed
54.
Zurück zum Zitat Choi CY, Chang SD, Gibbs IC et al (2012) What is the optimal treatment of large brain metastases? An argument for a multidisciplinary approach. Int J Radiat Oncol Biol Phys 84:688–693PubMed Choi CY, Chang SD, Gibbs IC et al (2012) What is the optimal treatment of large brain metastases? An argument for a multidisciplinary approach. Int J Radiat Oncol Biol Phys 84:688–693PubMed
55.
Zurück zum Zitat Ammirati M, Cobbs CS, Linskey ME et al (2010) The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:85–96PubMedCentralPubMed Ammirati M, Cobbs CS, Linskey ME et al (2010) The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:85–96PubMedCentralPubMed
56.
Zurück zum Zitat Patel SH, Robbins JR, Gore EM et al (2012) ACR Appropriateness Criteria(R) follow-up and retreatment of brain metastases. Am J Clin Oncol 35:302–306PubMed Patel SH, Robbins JR, Gore EM et al (2012) ACR Appropriateness Criteria(R) follow-up and retreatment of brain metastases. Am J Clin Oncol 35:302–306PubMed
57.
Zurück zum Zitat Chao ST, Barnett GH, Vogelbaum MA et al (2008) Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy. Cancer 113:2198–2204PubMed Chao ST, Barnett GH, Vogelbaum MA et al (2008) Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy. Cancer 113:2198–2204PubMed
58.
Zurück zum Zitat Yomo S, Hayashi M (2013) The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases. J Neurooncol 113:459–465PubMed Yomo S, Hayashi M (2013) The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases. J Neurooncol 113:459–465PubMed
59.
Zurück zum Zitat Kwon KY, Kong DS, Lee JI, Nam DH, Park K, Kim JH (2007) Endpoint of repeated radiosurgery for recurrent metastatic brain tumors. Clin Neurol Neurosurg 109:132–137PubMed Kwon KY, Kong DS, Lee JI, Nam DH, Park K, Kim JH (2007) Endpoint of repeated radiosurgery for recurrent metastatic brain tumors. Clin Neurol Neurosurg 109:132–137PubMed
60.
Zurück zum Zitat Johnson M, Baschnagel AM, Chen PY et al (2013) Analysis of risk factors for development of radiation necrosis following gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 87:S279 Johnson M, Baschnagel AM, Chen PY et al (2013) Analysis of risk factors for development of radiation necrosis following gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 87:S279
62.
Zurück zum Zitat Seung SK, Larson DA, Galvin JM et al (2013) American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS). Am J Clin Oncol 36:310–315PubMed Seung SK, Larson DA, Galvin JM et al (2013) American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS). Am J Clin Oncol 36:310–315PubMed
63.
Zurück zum Zitat Bortfeld T, Oelfke U, Nill S (2000) What is the optimum leaf width of a multileaf collimator? Med Phys 27:2494–2502 Bortfeld T, Oelfke U, Nill S (2000) What is the optimum leaf width of a multileaf collimator? Med Phys 27:2494–2502
64.
Zurück zum Zitat Treuer H, Kocher M, Hoevels M et al (2006) Impact of target point deviations on control and complication probabilities in stereotactic radiosurgery of AVMs and metastases. Radiother Oncol 81:25–32PubMed Treuer H, Kocher M, Hoevels M et al (2006) Impact of target point deviations on control and complication probabilities in stereotactic radiosurgery of AVMs and metastases. Radiother Oncol 81:25–32PubMed
65.
Zurück zum Zitat Hartmann GH, Lutz W, Arndt J et al (1995) Quality Assurance Program on Stereotactic Radiosurgery. Report From a Quality Assurance Task Group. Berlin Hartmann GH, Lutz W, Arndt J et al (1995) Quality Assurance Program on Stereotactic Radiosurgery. Report From a Quality Assurance Task Group. Berlin
66.
Zurück zum Zitat DIN_6875-1:2004-01 (2004) Spezielle Bestrahlungseinrichtungen—Teil 1: Perkutane stereotaktische Bestrahlung, Kennmerkmale und besondere Prüfmethoden DIN_6875-1:2004-01 (2004) Spezielle Bestrahlungseinrichtungen—Teil 1: Perkutane stereotaktische Bestrahlung, Kennmerkmale und besondere Prüfmethoden
67.
Zurück zum Zitat DIN_6875-2:2008-11 (2008) Spezielle Bestrahlungseinrichtungen – Teil 2: Perkutane stereotaktische Bestrahlung—Konstanzprüfungen DIN_6875-2:2008-11 (2008) Spezielle Bestrahlungseinrichtungen – Teil 2: Perkutane stereotaktische Bestrahlung—Konstanzprüfungen
68.
Zurück zum Zitat Dieterich S, Cavedon C, Chuang CF et al (2011) Report of AAPM TG 135: quality assurance for robotic radiosurgery. Med Phys 38:2914–2936 (Erratum: Med Phys 011 Sep;38: 5264) Dieterich S, Cavedon C, Chuang CF et al (2011) Report of AAPM TG 135: quality assurance for robotic radiosurgery. Med Phys 38:2914–2936 (Erratum: Med Phys 011 Sep;38: 5264)
69.
Zurück zum Zitat Klein EE, Hanley J, Bayouth J et al (2009) Task Group 142 report: quality assurance of medical accelerators. Med Phys 36:4197–4212PubMed Klein EE, Hanley J, Bayouth J et al (2009) Task Group 142 report: quality assurance of medical accelerators. Med Phys 36:4197–4212PubMed
70.
Zurück zum Zitat DIN_6875-3:2008:03 (2008) Spezielle Bestrahlungseinrichtungen—Teil 3: Fluenzmodulierte Strahlentherapie—Kennmerkmale, Prüfmethoden und Regeln für den klinischen Einsatz DIN_6875-3:2008:03 (2008) Spezielle Bestrahlungseinrichtungen—Teil 3: Fluenzmodulierte Strahlentherapie—Kennmerkmale, Prüfmethoden und Regeln für den klinischen Einsatz
71.
Zurück zum Zitat DIN_6875-4:2011:10 (2011) Spezielle Bestrahlungseinrichtungen—Teil 4: Fluenzmodulierte Strahlentherapie—Konstanzprüfungen DIN_6875-4:2011:10 (2011) Spezielle Bestrahlungseinrichtungen—Teil 4: Fluenzmodulierte Strahlentherapie—Konstanzprüfungen
72.
Zurück zum Zitat Ezzell GA, Galvin JM, Low D et al (2003) Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys 30:2089–2115PubMed Ezzell GA, Galvin JM, Low D et al (2003) Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys 30:2089–2115PubMed
74.
Zurück zum Zitat Aspradakis MM, Byrne JP, Palmans H et al (2010) Small field MV photon dosimetry. IPEM Reports Series (Institute of Physics and Engineering in Medicine) Aspradakis MM, Byrne JP, Palmans H et al (2010) Small field MV photon dosimetry. IPEM Reports Series (Institute of Physics and Engineering in Medicine)
75.
Zurück zum Zitat DIN 6809-8 ip (2013) Klinische Dosimetrie—Teil 8: Dosimetrie kleiner Photonen-Bestrahlungsfelder DIN 6809-8 ip (2013) Klinische Dosimetrie—Teil 8: Dosimetrie kleiner Photonen-Bestrahlungsfelder
76.
Zurück zum Zitat Bichay T, Dieterich S, Orton CG. (2013) Submillimeter accuracy in radiosurgery is not possible. Med Phys 40:050601. doi:10.1118/1.4790690 Bichay T, Dieterich S, Orton CG. (2013) Submillimeter accuracy in radiosurgery is not possible. Med Phys 40:050601. doi:10.1118/1.4790690
77.
Zurück zum Zitat Lutz W, Winston KR, Maleki N (1988) A system for stereotactic radiosurgery with a linear accelerator. Int J Radiat Oncol Biol Phys 14:373–381PubMed Lutz W, Winston KR, Maleki N (1988) A system for stereotactic radiosurgery with a linear accelerator. Int J Radiat Oncol Biol Phys 14:373–381PubMed
78.
Zurück zum Zitat Antypas C, Pantelis E (2008) Performance evaluation of a CyberKnife G4 image-guided robotic stereotactic radiosurgery system. Phys Med Biol 53:4697–4718PubMed Antypas C, Pantelis E (2008) Performance evaluation of a CyberKnife G4 image-guided robotic stereotactic radiosurgery system. Phys Med Biol 53:4697–4718PubMed
79.
Zurück zum Zitat Wiehle R, Koth HJ, Nanko N, Grosu AL, Hodapp N (2009) On the accuracy of isocenter verification with kV imaging in stereotactic radiosurgery. Strahlenther Onkol 185:325–330PubMed Wiehle R, Koth HJ, Nanko N, Grosu AL, Hodapp N (2009) On the accuracy of isocenter verification with kV imaging in stereotactic radiosurgery. Strahlenther Onkol 185:325–330PubMed
80.
Zurück zum Zitat Chang J, Yenice KM, Narayana A, Gutin PH (2007) Accuracy and feasibility of cone-beam computed tomography for stereotactic radiosurgery setup. Med Phys 34:2077–2084PubMed Chang J, Yenice KM, Narayana A, Gutin PH (2007) Accuracy and feasibility of cone-beam computed tomography for stereotactic radiosurgery setup. Med Phys 34:2077–2084PubMed
81.
Zurück zum Zitat Masi L, Casamassima F, Polli C, Menichelli C, Bonucci I, Cavedon C (2008) Cone beam CT image guidance for intracranial stereotactic treatments: comparison with a frame guided set-up. Int J Radiat Oncol Biol Phys 71:926–933PubMed Masi L, Casamassima F, Polli C, Menichelli C, Bonucci I, Cavedon C (2008) Cone beam CT image guidance for intracranial stereotactic treatments: comparison with a frame guided set-up. Int J Radiat Oncol Biol Phys 71:926–933PubMed
82.
Zurück zum Zitat Fuss M, Salter BJ, Cheek D, Sadeghi A, Hevezi JM, Herman T (2004) Repositioning accuracy of a commercially available thermoplastic mask system. Radiother Oncol 71:339–345PubMed Fuss M, Salter BJ, Cheek D, Sadeghi A, Hevezi JM, Herman T (2004) Repositioning accuracy of a commercially available thermoplastic mask system. Radiother Oncol 71:339–345PubMed
83.
Zurück zum Zitat Baumert BG, Egli P, Studer S, Dehing C, Davis JB (2005) Repositioning accuracy of fractionated stereotactic irradiation: assessment of isocentre alignment for different dental fixations by using sequential CT scanning. Radiother Oncol 74:61–66PubMed Baumert BG, Egli P, Studer S, Dehing C, Davis JB (2005) Repositioning accuracy of fractionated stereotactic irradiation: assessment of isocentre alignment for different dental fixations by using sequential CT scanning. Radiother Oncol 74:61–66PubMed
84.
Zurück zum Zitat Guckenberger M, Roesch J, Baier K, Sweeney RA, Flentje M (2012) Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery. Radiat Oncol 7:63PubMedCentralPubMed Guckenberger M, Roesch J, Baier K, Sweeney RA, Flentje M (2012) Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery. Radiat Oncol 7:63PubMedCentralPubMed
85.
Zurück zum Zitat Gevaert T, Verellen D, Engels B et al (2012) Clinical evaluation of a robotic 6-degree of freedom treatment couch for frameless radiosurgery. Int J Radiat Oncol Biol Phys 83:467–474PubMed Gevaert T, Verellen D, Engels B et al (2012) Clinical evaluation of a robotic 6-degree of freedom treatment couch for frameless radiosurgery. Int J Radiat Oncol Biol Phys 83:467–474PubMed
86.
Zurück zum Zitat Minniti G, Scaringi C, Clarke E, Valeriani M, Osti M, Enrici RM (2011) Frameless linac-based stereotactic radiosurgery (SRS) for brain metastases: analysis of patient repositioning using a mask fixation system and clinical endpoints. Radiat Oncol 6:158PubMedCentralPubMed Minniti G, Scaringi C, Clarke E, Valeriani M, Osti M, Enrici RM (2011) Frameless linac-based stereotactic radiosurgery (SRS) for brain metastases: analysis of patient repositioning using a mask fixation system and clinical endpoints. Radiat Oncol 6:158PubMedCentralPubMed
87.
Zurück zum Zitat Ramakrishna N, Rosca F, Friesen S, Tezcanli E, Zygmanszki P, Hacker F (2010) A clinical comparison of patient setup and intra-fraction motion using frame-based radiosurgery versus a frameless image-guided radiosurgery system for intracranial lesions. Radiother Oncol 95:109–115PubMed Ramakrishna N, Rosca F, Friesen S, Tezcanli E, Zygmanszki P, Hacker F (2010) A clinical comparison of patient setup and intra-fraction motion using frame-based radiosurgery versus a frameless image-guided radiosurgery system for intracranial lesions. Radiother Oncol 95:109–115PubMed
88.
Zurück zum Zitat Minniti G, Valeriani M, Clarke E et al (2010) Fractionated Stereotactic Radiotherapy for skull base tumors: analysis of treatment accuracy using a stereotactic mask fixation system. Radiat Oncol 5:1PubMedCentralPubMed Minniti G, Valeriani M, Clarke E et al (2010) Fractionated Stereotactic Radiotherapy for skull base tumors: analysis of treatment accuracy using a stereotactic mask fixation system. Radiat Oncol 5:1PubMedCentralPubMed
89.
Zurück zum Zitat Theelen A, Martens J, Bosmans G et al (2012) Relocatable fixation systems in intracranial Stereotactic Radiotherapy. Accuracy of serial CT scans and patient acceptance in a randomized design. Strahlenther Onkol 188:84–90PubMed Theelen A, Martens J, Bosmans G et al (2012) Relocatable fixation systems in intracranial Stereotactic Radiotherapy. Accuracy of serial CT scans and patient acceptance in a randomized design. Strahlenther Onkol 188:84–90PubMed
90.
Zurück zum Zitat Sperduto PW (2010) What is your patient’s GPA and why does it matter? Managing brain metastases and the cost of hope. Int J Radiat Oncol Biol Phys 77:643–644PubMed Sperduto PW (2010) What is your patient’s GPA and why does it matter? Managing brain metastases and the cost of hope. Int J Radiat Oncol Biol Phys 77:643–644PubMed
91.
Zurück zum Zitat Fokas E, Henzel M, Surber G, Kleinert G, Hamm K, Engenhart-Cabillic R (2012) Stereotactic radiosurgery and fractionated Stereotactic Radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases. J Neurooncol 109:91–98PubMed Fokas E, Henzel M, Surber G, Kleinert G, Hamm K, Engenhart-Cabillic R (2012) Stereotactic radiosurgery and fractionated Stereotactic Radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases. J Neurooncol 109:91–98PubMed
92.
Zurück zum Zitat Wegner RE, Leeman JE, Kabolizadeh P et al (2013) Fractionated Stereotactic Radiosurgery for Large Brain Metastases. Am J Clin Oncol [Epub ahead of print] Wegner RE, Leeman JE, Kabolizadeh P et al (2013) Fractionated Stereotactic Radiosurgery for Large Brain Metastases. Am J Clin Oncol [Epub ahead of print]
93.
Zurück zum Zitat Yamamoto M (2013) 147 Gamma knife treatment results for multiple brain metastases: a multi-institutional prospective study in Japan (Abbreviation; JLGK0901, UMIN ID; 00001812). Neurosurgery 60:168–169 Yamamoto M (2013) 147 Gamma knife treatment results for multiple brain metastases: a multi-institutional prospective study in Japan (Abbreviation; JLGK0901, UMIN ID; 00001812). Neurosurgery 60:168–169
94.
Zurück zum Zitat Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD (2006) Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 64:898–903PubMed Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD (2006) Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 64:898–903PubMed
95.
Zurück zum Zitat Kuo T, Recht L (2006) Optimizing therapy for patients with brain metastases. Semin Oncol 33:299–306PubMed Kuo T, Recht L (2006) Optimizing therapy for patients with brain metastases. Semin Oncol 33:299–306PubMed
96.
Zurück zum Zitat Suh JH, Videtic GM, Aref AM et al (2010) ACR Appropriateness Criteria: single brain metastasis. Curr Probl Cancer 34:162–174PubMed Suh JH, Videtic GM, Aref AM et al (2010) ACR Appropriateness Criteria: single brain metastasis. Curr Probl Cancer 34:162–174PubMed
97.
Zurück zum Zitat Sze G, Milano E, Johnson C, Heier L (1990) Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 11:785–791PubMed Sze G, Milano E, Johnson C, Heier L (1990) Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 11:785–791PubMed
98.
Zurück zum Zitat Anzalone N, Essig M, Lee SK et al (2013) Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery. Neurosurgery 72:691–701PubMed Anzalone N, Essig M, Lee SK et al (2013) Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery. Neurosurgery 72:691–701PubMed
99.
Zurück zum Zitat Pantelis E, Papadakis N, Verigos K et al (2010) Integration of functional MRI and white matter tractography in stereotactic radiosurgery clinical practice. Int J Radiat Oncol Biol Phys 78:257–267PubMed Pantelis E, Papadakis N, Verigos K et al (2010) Integration of functional MRI and white matter tractography in stereotactic radiosurgery clinical practice. Int J Radiat Oncol Biol Phys 78:257–267PubMed
100.
Zurück zum Zitat Baumert BG, Rutten I, Dehing-Oberije C et al (2006) A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 66:187–194PubMed Baumert BG, Rutten I, Dehing-Oberije C et al (2006) A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 66:187–194PubMed
101.
Zurück zum Zitat Noël G, Simon JM, Valery CA et al (2003) Radiosurgery for brain metastasis: impact of CTV on local control. Radiother Oncol 68:15–21PubMed Noël G, Simon JM, Valery CA et al (2003) Radiosurgery for brain metastasis: impact of CTV on local control. Radiother Oncol 68:15–21PubMed
102.
Zurück zum Zitat Nataf F, Schlienger M, Liu Z et al (2008) Radiosurgery with or without a 2-mm margin for 93 single brain metastases. Int J Radiat Oncol Biol Phys 70:766–772 Nataf F, Schlienger M, Liu Z et al (2008) Radiosurgery with or without a 2-mm margin for 93 single brain metastases. Int J Radiat Oncol Biol Phys 70:766–772
103.
Zurück zum Zitat Flickinger JC, Schell MC, Larson DA (1990) Estimation of complications for linear accelerator radiosurgery with the integrated logistic formula. Int J Radiat Oncol Biol Phys 19:143–148PubMed Flickinger JC, Schell MC, Larson DA (1990) Estimation of complications for linear accelerator radiosurgery with the integrated logistic formula. Int J Radiat Oncol Biol Phys 19:143–148PubMed
104.
Zurück zum Zitat Telera S, Fabi A, Pace A et al (2013) Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and endpoint of disease. J Neurooncol 113:313–325PubMed Telera S, Fabi A, Pace A et al (2013) Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and endpoint of disease. J Neurooncol 113:313–325PubMed
105.
Zurück zum Zitat Maldaun MV, Aguiar PH, Lang F, Suki D, Wildrick D, Sawaya R (2008) Radiosurgery in the treatment of brain metastases: critical review regarding complications. Neurosurg Rev 31:1–8; discussion 9 Maldaun MV, Aguiar PH, Lang F, Suki D, Wildrick D, Sawaya R (2008) Radiosurgery in the treatment of brain metastases: critical review regarding complications. Neurosurg Rev 31:1–8; discussion 9
106.
Zurück zum Zitat Dequesada IM, Quisling RG, Yachnis A, Friedman WA (2008) Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 63:898–903; discussion 4 Dequesada IM, Quisling RG, Yachnis A, Friedman WA (2008) Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 63:898–903; discussion 4
107.
Zurück zum Zitat Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC (2010) Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77:996–1001PubMed Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC (2010) Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77:996–1001PubMed
108.
Zurück zum Zitat Shehata MK, Young B, Reid B et al (2004) Stereotatic radiosurgery of 468 brain metastases < or = 2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 59:87–93PubMed Shehata MK, Young B, Reid B et al (2004) Stereotatic radiosurgery of 468 brain metastases < or = 2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 59:87–93PubMed
109.
Zurück zum Zitat Voges J, Treuer H, Sturm V et al (1996) Risk analysis of linear accelerator radiosurgery. Int J Radiat Oncol Biol Phys 36:1055–1063PubMed Voges J, Treuer H, Sturm V et al (1996) Risk analysis of linear accelerator radiosurgery. Int J Radiat Oncol Biol Phys 36:1055–1063PubMed
110.
Zurück zum Zitat Lawrence YR, Li XA, el Naqa I et al (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76:S20–S27 Lawrence YR, Li XA, el Naqa I et al (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76:S20–S27
111.
Zurück zum Zitat Marks LB, Yorke ED, Jackson A et al (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76:S10–S19PubMed Marks LB, Yorke ED, Jackson A et al (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76:S10–S19PubMed
112.
Zurück zum Zitat Paddick I (2000) Simple scoring ratio to index the conformity of radiosurgical treatment plans. J Neurosurg 93:219–222PubMed Paddick I (2000) Simple scoring ratio to index the conformity of radiosurgical treatment plans. J Neurosurg 93:219–222PubMed
113.
Zurück zum Zitat Lamm AF, Elaimy AL, Lamoreaux WT et al (2013) A review of the clinical outcomes for patients diagnosed with brainstem metastasis and treated with stereotactic radiosurgery. ISRN Surg 2013:652895PubMedCentralPubMed Lamm AF, Elaimy AL, Lamoreaux WT et al (2013) A review of the clinical outcomes for patients diagnosed with brainstem metastasis and treated with stereotactic radiosurgery. ISRN Surg 2013:652895PubMedCentralPubMed
114.
Zurück zum Zitat Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH (2006) Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104:907–912PubMed Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH (2006) Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104:907–912PubMed
115.
Zurück zum Zitat Mayo C, Yorke E, Merchant TE (2010) Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys 76:S36–S41 Mayo C, Yorke E, Merchant TE (2010) Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys 76:S36–S41
116.
Zurück zum Zitat Sharma MS, Kondziolka D, Khan A et al (2008) Radiation tolerance limits of the brainstem. Neurosurgery 63:728–32; discussion 32–3 Sharma MS, Kondziolka D, Khan A et al (2008) Radiation tolerance limits of the brainstem. Neurosurgery 63:728–32; discussion 32–3
117.
Zurück zum Zitat Patel TR, McHugh BJ, Bi WL, Minja FJ, Knisely JP, Chiang VL (2011) A comprehensive review of MR imaging changes following radiosurgery to 500 brain metastases. AJNR Am J Neuroradiol 32:1885–1892PubMed Patel TR, McHugh BJ, Bi WL, Minja FJ, Knisely JP, Chiang VL (2011) A comprehensive review of MR imaging changes following radiosurgery to 500 brain metastases. AJNR Am J Neuroradiol 32:1885–1892PubMed
118.
Zurück zum Zitat Brandsma D, Stalpers L, Taal W, Sminia P, Van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453–461PubMed Brandsma D, Stalpers L, Taal W, Sminia P, Van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453–461PubMed
119.
Zurück zum Zitat Brandsma D, Van den Bent MJ (2009) Pseudoprogression and pseudoresponse in the treatment of gliomas. Curr Opin Neurol 22:633–638PubMed Brandsma D, Van den Bent MJ (2009) Pseudoprogression and pseudoresponse in the treatment of gliomas. Curr Opin Neurol 22:633–638PubMed
120.
Zurück zum Zitat Chamberlain MC (2008) Pseudoprogression in glioblastoma. J Clin Oncol 26:4359–4360PubMed Chamberlain MC (2008) Pseudoprogression in glioblastoma. J Clin Oncol 26:4359–4360PubMed
121.
Zurück zum Zitat Tran DK, Jensen RL (2013) So-called “pseudoprogression” vs. tumor progression: review and future research opportunities. Surg Neurol Int 4:S129–S135PubMedCentralPubMed Tran DK, Jensen RL (2013) So-called “pseudoprogression” vs. tumor progression: review and future research opportunities. Surg Neurol Int 4:S129–S135PubMedCentralPubMed
122.
Zurück zum Zitat Grosu AL, Astner ST, Riedel E et al (2011) An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases. Int J Radiat Oncol Biol Phys 81:1049–1058PubMed Grosu AL, Astner ST, Riedel E et al (2011) An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases. Int J Radiat Oncol Biol Phys 81:1049–1058PubMed
123.
Zurück zum Zitat Galldiks N, Stoffels G, Filss CP et al (2012) Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med 53:1367–1374PubMed Galldiks N, Stoffels G, Filss CP et al (2012) Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med 53:1367–1374PubMed
124.
Zurück zum Zitat Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, Cha S (2009) Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 30:367–372PubMed Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, Cha S (2009) Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 30:367–372PubMed
125.
Zurück zum Zitat Sundgren PC (2009) MR spectroscopy in radiation injury. AJNR Am J Neuroradiol 30:1469–1476PubMed Sundgren PC (2009) MR spectroscopy in radiation injury. AJNR Am J Neuroradiol 30:1469–1476PubMed
126.
Zurück zum Zitat Kickingereder P, Dorn F, Blau T et al (2013) Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature. Radiat Oncol 8:52PubMedCentralPubMed Kickingereder P, Dorn F, Blau T et al (2013) Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature. Radiat Oncol 8:52PubMedCentralPubMed
127.
Zurück zum Zitat Bhangoo SS, Linskey ME, Kalkanis SN (2011) Evidence-based guidelines for the management of brain metastases. Neurosurg Clin N Am 22:97–104PubMed Bhangoo SS, Linskey ME, Kalkanis SN (2011) Evidence-based guidelines for the management of brain metastases. Neurosurg Clin N Am 22:97–104PubMed
128.
Zurück zum Zitat Network NCC (2012) Central nervous system cancers NCCN guidelines for treatment of cancer by site Network NCC (2012) Central nervous system cancers NCCN guidelines for treatment of cancer by site
129.
Zurück zum Zitat Weller M, Schlegel U, Wick W et al (2011) Hirnmetastasen und Meningeosis neoplastica. Leitlinien der Deutschen Gesellschaft für Neurologie. AWMF online 2011;AWMF-Register 030/060:Stand 9/2011. Weller M, Schlegel U, Wick W et al (2011) Hirnmetastasen und Meningeosis neoplastica. Leitlinien der Deutschen Gesellschaft für Neurologie. AWMF online 2011;AWMF-Register 030/060:Stand 9/2011.
130.
Zurück zum Zitat D’Ambrosio AL, DeYoung C, Isaacson SR (2011) Radiosurgical management of brain metastases. Neurosurg Clin N Am 22:45–51PubMed D’Ambrosio AL, DeYoung C, Isaacson SR (2011) Radiosurgical management of brain metastases. Neurosurg Clin N Am 22:45–51PubMed
131.
Zurück zum Zitat Kondziolka D, Flickinger JC, Lunsford LD (2012) Radiosurgery for brain metastases. In: Kim DG, Lunsford LD (eds) Current and future management of brain metastasis. Karger AG, Basel Kondziolka D, Flickinger JC, Lunsford LD (2012) Radiosurgery for brain metastases. In: Kim DG, Lunsford LD (eds) Current and future management of brain metastasis. Karger AG, Basel
132.
Zurück zum Zitat Niranjan A, Lunsford LD, Emerick RL (2012) Stereotactic radiosurgery for patients with metastatic brain tumors: development of a consensus radiosurgery guideline recommendation. In: Kim DG, Lunsford LD (eds) Current and future management of brain metastasis. Karger AG, Basel, pp 123–138 Niranjan A, Lunsford LD, Emerick RL (2012) Stereotactic radiosurgery for patients with metastatic brain tumors: development of a consensus radiosurgery guideline recommendation. In: Kim DG, Lunsford LD (eds) Current and future management of brain metastasis. Karger AG, Basel, pp 123–138
133.
Zurück zum Zitat Scoccianti S, Detti B, Cipressi S, Iannalfi A, Franzese C, Biti G (2012) Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy. J Neurooncol 108:291–308PubMed Scoccianti S, Detti B, Cipressi S, Iannalfi A, Franzese C, Biti G (2012) Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy. J Neurooncol 108:291–308PubMed
134.
Zurück zum Zitat Thavarajah N, Wong K, Zhang L et al (2013) Continued success in providing timely palliative radiation therapy at the Rapid Response Radiotherapy Program: a review of 2008–2012. Curr Oncol 20:e206–e211 Thavarajah N, Wong K, Zhang L et al (2013) Continued success in providing timely palliative radiation therapy at the Rapid Response Radiotherapy Program: a review of 2008–2012. Curr Oncol 20:e206–e211
Metadaten
Titel
Stereotactic radiosurgery for treatment of brain metastases
A report of the DEGRO Working Group on Stereotactic Radiotherapy
verfasst von
Prof. Dr. Martin Kocher, M.D.
Andrea Wittig, M.D.
Marc Dieter Piroth, M.D.
Harald Treuer, Ph.D.
Heinrich Seegenschmiedt, M.D.
Maximilian Ruge, M.D.
Anca-Ligia Grosu, M.D.
Matthias Guckenberger, M.D.
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 6/2014
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-014-0648-7

Weitere Artikel der Ausgabe 6/2014

Strahlentherapie und Onkologie 6/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.